NexgenRx Inc. (TSXV:NXG)
Canada
· Delayed Price · Currency is CAD 0.360
0.00 (0.00%)
At close: Apr 27, 2026
NexgenRx Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 17.48 | 15.9 | 13.29 | 12.57 | 11.79 | Upgrade
|
| Other Revenue | 0.46 | 0.58 | 0.56 | 0.21 | 0.05 | Upgrade
|
| Revenue | 17.93 | 16.48 | 13.85 | 12.78 | 11.84 | Upgrade
|
| Revenue Growth (YoY) | 8.84% | 18.99% | 8.33% | 7.94% | 12.01% | Upgrade
|
| Cost of Revenue | 3 | 3.35 | 3.03 | 2.6 | 2.03 | Upgrade
|
| Gross Profit | 14.93 | 13.12 | 10.82 | 10.18 | 9.81 | Upgrade
|
| Selling, General & Admin | 11.47 | 10.64 | 9.62 | 8.43 | 6.18 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.98 | 1.05 | 1.12 | 1.14 | 1.02 | Upgrade
|
| Operating Expenses | 12.7 | 11.92 | 10.96 | 9.9 | 7.61 | Upgrade
|
| Operating Income | 2.23 | 1.2 | -0.14 | 0.29 | 2.2 | Upgrade
|
| Interest Expense | -0.03 | -0.03 | -0.03 | -0.02 | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.15 | -0.14 | -0.13 | -0.13 | -0.13 | Upgrade
|
| EBT Excluding Unusual Items | 2.06 | 1.03 | -0.31 | 0.13 | 2.01 | Upgrade
|
| Impairment of Goodwill | -0.16 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.04 | - | - | - | - | Upgrade
|
| Pretax Income | 1.94 | 1.03 | -0.31 | 0.13 | 2.01 | Upgrade
|
| Income Tax Expense | 0.65 | 0.41 | 0.03 | 0.16 | -2.01 | Upgrade
|
| Net Income | 1.29 | 0.61 | -0.33 | -0.02 | 4.02 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.23 | 0.2 | 0.2 | - | - | Upgrade
|
| Net Income to Common | 1.06 | 0.42 | -0.53 | -0.02 | 4.02 | Upgrade
|
| Net Income Growth | 109.86% | - | - | - | 89.91% | Upgrade
|
| Shares Outstanding (Basic) | 71 | 71 | 71 | 70 | 70 | Upgrade
|
| Shares Outstanding (Diluted) | 77 | 77 | 71 | 70 | 75 | Upgrade
|
| Shares Change (YoY) | 0.68% | 8.51% | 0.28% | -6.01% | 0.88% | Upgrade
|
| EPS (Basic) | 0.01 | 0.01 | -0.01 | -0.00 | 0.06 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.01 | -0.01 | -0.00 | 0.05 | Upgrade
|
| EPS Growth | 180.00% | - | - | - | 86.21% | Upgrade
|
| Free Cash Flow | 4.68 | 1.06 | 1.2 | 0.68 | 3.7 | Upgrade
|
| Free Cash Flow Per Share | 0.06 | 0.01 | 0.02 | 0.01 | 0.05 | Upgrade
|
| Dividend Per Share | 0.015 | 0.010 | 0.010 | 0.010 | - | Upgrade
|
| Dividend Growth | 50.00% | - | - | - | - | Upgrade
|
| Gross Margin | 83.28% | 79.65% | 78.14% | 79.67% | 82.88% | Upgrade
|
| Operating Margin | 12.45% | 7.27% | -1.04% | 2.25% | 18.57% | Upgrade
|
| Profit Margin | 5.90% | 2.53% | -3.83% | -0.18% | 33.93% | Upgrade
|
| Free Cash Flow Margin | 26.10% | 6.46% | 8.67% | 5.30% | 31.23% | Upgrade
|
| EBITDA | 2.46 | 1.41 | 0.07 | 1.53 | 3.31 | Upgrade
|
| EBITDA Margin | 13.72% | 8.53% | 0.49% | 11.98% | 27.98% | Upgrade
|
| D&A For EBITDA | 0.23 | 0.21 | 0.21 | 1.24 | 1.11 | Upgrade
|
| EBIT | 2.23 | 1.2 | -0.14 | 0.29 | 2.2 | Upgrade
|
| EBIT Margin | 12.45% | 7.27% | -1.04% | 2.25% | 18.57% | Upgrade
|
| Effective Tax Rate | 33.37% | 40.14% | - | 116.66% | - | Upgrade
|
| Revenue as Reported | 17.93 | 16.48 | 13.85 | 12.78 | 11.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.